Company Filing History:
Years Active: 1998-2000
Title: Innovations by Inventor John Leong in Recombinant Cloning Technologies
Introduction
John Leong is a notable inventor based in San Francisco, CA, whose work has significantly contributed to the field of biotechnology. With a total of four patents to his name, Leong has pioneered advancements in recombinant cloning processes that are crucial for genetic research and development.
Latest Patents
One of Leong's latest inventions is a recombinant clone selection system. This innovative cloning system is designed for the isolation of recombinant nucleic acid. It presents a unique method where the recombination of cloning-system nucleic acid and foreign nucleic acid is connected to the expression of a moiety on the surface of a host organism. This moiety acts as the first member of a binding pair. When recombination occurs, the moiety is expressed on the host organism's surface. To isolate the recombinant nucleic acid, a second member of the binding pair is attached to a solid support, and when the host organism is contacted with this support, organisms with the expressed moiety bind selectively to it. This method has enormous implications for enhancing the precision and efficiency of genetic manipulation.
Career Highlights
Leong is currently associated with the PerkinElmer Corporation, a leading company in the fields of diagnostics, life sciences, and environmental monitoring. His career has been defined by his commitment to innovation, resulting in the development of advanced cloning techniques that aid various research initiatives.
Collaborations
Throughout his career, John Leong has collaborated with distinguished colleagues such as John A. Bridgham and John Brandis. These collaborations have enriched his work, leading to groundbreaking advancements within the biotechnology sector and further enhancing the impact of his inventions.
Conclusion
John Leong stands out as a dynamic inventor whose innovations in recombinant cloning systems continue to shape biotechnological research. With a solid foundation of patents that underscore his expertise and contributions, he is poised to remain a key figure in the ongoing evolution of genetic engineering.